Dec 11, 2020
How can clinical trial organizations achieve TMF excellence? That’s one of the important issues discussed in Sholeh Ehdaivand’s interview with Linda Sullivan, MBA, Executive Director of WCG’s Metric Champion Consortium (MCC). Ehdaivand, President and CEO of LMK Clinical Research Consulting, a certified woman-owned...
Dec 9, 2020
Can metrics play a crucial oversight role in establishing an effective and efficient relationship between sponsors and CROs? That’s one of the important issues discussed in Steve Crow’s and Keith Dorricott’s interview with Linda Sullivan, MBA, Executive Director of WCG’s Metric Champion Consortium (MCC). Crow,...
Nov 12, 2020
What’s the best way to get rid of unproductive waste in clinical trials? That’s one of the important issues discussed in Keith Doricottt’s interview with Linda Sullivan, MBA, Executive Director of WCG’s Metric Champion Consortium (MCC). Keith Dorricott, a Lean Six?? Sigma Master Black Belt with extensive...
Oct 13, 2020
Should Risk-Based Quality Management (RBQM) begin with technology or process? That’s one of the important issues discussed in Gary Tyson’s interview with Linda Sullivan, MBA, Executive Director of WCG’s Metric Champion Consortium (MCC). Tyson founded Pharma Initiatives eight years ago after the sale of...
Sep 23, 2020
How can sponsors, CROs, and sites improve the performance of clinical researchers? That’s one of the important issues discussed in SAM Sather’s interview with Linda Sullivan, MBA, Executive Director of WCG’s Metric Champion Consortium (MCC). Sather, Cofounder and Vice President of Clinical Pathways (CP), LLC,...